Clorox Company (The) (CLX) Rating Reiterated by BMO Capital Markets

Clorox Company (The) (NYSE:CLX)‘s stock had its “outperform” rating restated by stock analysts at BMO Capital Markets in a report released on Tuesday.

Other equities analysts also recently issued reports about the company. Deutsche Bank AG reaffirmed a “hold” rating and set a $137.00 price target (up from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. BidaskClub downgraded Clorox Company (The) from a “hold” rating to a “sell” rating in a research report on Wednesday, July 5th. Zacks Investment Research raised Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price target on the stock in a research report on Tuesday, July 4th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $115.00 price target on shares of Clorox Company (The) in a research report on Friday, June 30th. Finally, Barclays PLC reaffirmed an “equal weight” rating and set a $136.00 price target (down from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $129.05.

Clorox Company (CLX) opened at 135.03 on Tuesday. The company has a market cap of $17.43 billion, a price-to-earnings ratio of 25.31 and a beta of 0.40. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76. The company’s 50-day moving average price is $135.68 and its 200-day moving average price is $135.26.

Clorox Company (The) (NYSE:CLX) last posted its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.04. The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. Clorox Company (The)’s revenue was up 2.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.30 earnings per share. Equities research analysts expect that Clorox Company will post $5.66 EPS for the current fiscal year.

WARNING: This story was first posted by Markets Daily and is the property of of Markets Daily. If you are accessing this story on another publication, it was copied illegally and reposted in violation of international copyright laws. The legal version of this story can be viewed at https://www.themarketsdaily.com/2017/09/12/clorox-company-the-clx-rating-reiterated-by-bmo-capital-markets.html.

In related news, SVP Jon M. Balousek sold 9,223 shares of the company’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total value of $1,280,798.01. Following the transaction, the senior vice president now directly owns 20,614 shares of the company’s stock, valued at approximately $2,862,666.18. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Dawn C. Willoughby sold 2,158 shares of the company’s stock in a transaction on Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total value of $297,804.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 21,242 shares of company stock worth $2,944,449. 0.74% of the stock is owned by insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its position in shares of Clorox Company (The) by 2.6% in the 2nd quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock valued at $1,936,595,000 after acquiring an additional 369,918 shares during the period. BlackRock Inc. increased its position in shares of Clorox Company (The) by 1,402.2% in the 1st quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock valued at $1,400,912,000 after acquiring an additional 9,698,542 shares during the period. State Street Corp increased its position in shares of Clorox Company (The) by 2.2% in the 1st quarter. State Street Corp now owns 7,648,999 shares of the company’s stock valued at $1,031,304,000 after acquiring an additional 167,689 shares during the period. Wells Fargo & Company MN increased its position in shares of Clorox Company (The) by 5.3% in the 2nd quarter. Wells Fargo & Company MN now owns 4,412,600 shares of the company’s stock valued at $587,934,000 after acquiring an additional 221,168 shares during the period. Finally, Parnassus Investments CA acquired a new position in shares of Clorox Company (The) in the 1st quarter valued at $434,255,000. 71.28% of the stock is currently owned by hedge funds and other institutional investors.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply